| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.18 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |